These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12171558)

  • 41. Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.
    Angibaud P; Arts J; Van Emelen K; Poncelet V; Pilatte I; Roux B; Van Brandt S; Verdonck M; De Winter H; Ten Holte P; Marien A; Floren W; Janssens B; Van Dun J; Aerts A; Van Gompel J; Gaurrand S; Queguiner L; Argoullon JM; Van Hijfte L; Freyne E; Janicot M
    Eur J Med Chem; 2005 Jun; 40(6):597-606. PubMed ID: 15922843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.
    Cherney RJ; Wang L; Meyer DT; Xue CB; Arner EC; Copeland RA; Covington MB; Hardman KD; Wasserman ZR; Jaffee BD; Decicco CP
    Bioorg Med Chem Lett; 1999 May; 9(9):1279-84. PubMed ID: 10340614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
    Antczak C; Shum D; Bassit B; Frattini MG; Li Y; de Stanchina E; Scheinberg DA; Djaballah H
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4528-32. PubMed ID: 21719286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
    Flipo M; Beghyn T; Charton J; Leroux VA; Deprez BP; Deprez-Poulain RF
    Bioorg Med Chem; 2007 Jan; 15(1):63-76. PubMed ID: 17070058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
    Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
    Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid assembly of matrix metalloprotease inhibitors using click chemistry.
    Wang J; Uttamchandani M; Li J; Hu M; Yao SQ
    Org Lett; 2006 Aug; 8(17):3821-4. PubMed ID: 16898826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
    Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
    J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.
    Becker DP; Barta TE; Bedell L; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Mischke B; Munie GE; Swearingen C; Villamil CI
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2719-22. PubMed ID: 11591509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A.
    Doherty W; Dürr EM; Baddock HT; Lee SY; McHugh PJ; Brown T; Senge MO; Scanlan EM; McGouran JF
    Org Biomol Chem; 2019 Sep; 17(35):8094-8105. PubMed ID: 31380542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-substituted hydroxamic acids as novel bacterial deformylase inhibitor-based antibacterial agents.
    Jain R; Sundram A; Lopez S; Neckermann G; Wu C; Hackbarth C; Chen D; Wang W; Ryder NS; Weidmann B; Patel D; Trias J; White R; Yuan Z
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4223-8. PubMed ID: 14623006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors.
    Tischler JL; Abuaita B; Cuthpert SC; Fage C; Murphy K; Saxe A; Furr EB; Hedrick J; Meyers J; Snare D; Zand AR
    J Enzyme Inhib Med Chem; 2008 Aug; 23(4):549-55. PubMed ID: 18608778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Principles of hydroxamate inhibition of metalloproteases: carboxypeptidase A.
    Mock WL; Cheng H
    Biochemistry; 2000 Nov; 39(45):13945-52. PubMed ID: 11076537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties.
    Pirrung MC; Tumey LN; McClerren AL; Raetz CR
    J Am Chem Soc; 2003 Feb; 125(6):1575-86. PubMed ID: 12568618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
    Thunnissen MM; Andersson B; Samuelsson B; Wong CH; Haeggström J
    FASEB J; 2002 Oct; 16(12):1648-50. PubMed ID: 12207002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.
    Duan JJ; Lu Z; Wasserman ZR; Liu RQ; Covington MB; Decicco CP
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2970-3. PubMed ID: 15908214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The development of MetAP-2 inhibitors in cancer treatment.
    Yin SQ; Wang JJ; Zhang CM; Liu ZP
    Curr Med Chem; 2012; 19(7):1021-35. PubMed ID: 22229417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.
    Becker DP; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Munie GE; Swearingen C
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2723-5. PubMed ID: 11591510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory activities of semicarbazide-sensitive amine oxidase and angiotensin converting enzyme of pectin hydroxamic acid.
    Hou WC; Lee MH; Hsu FL; Lin YH
    J Agric Food Chem; 2003 Oct; 51(21):6362-6. PubMed ID: 14518968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfonate ester hydroxamic acids as potent and selective inhibitors of TACE enzyme.
    Levin JI; Du MT
    Drug Des Discov; 2003; 18(4):123-6. PubMed ID: 15553924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.